系統性血管炎與腎臟損傷

Systemic Vasculitis and Renal Dysfunction

10.3966/172674042016061502001

翁淑滿(Shu-Man Weng)；江慧珠(Hui-Chu Chiang)

系統性血管炎 ； 腎臟功能障礙 ； 護理 ； systemic vasculitis ； renal dysfunction ； nursing

臺灣腎臟護理學會雜誌

15卷2期（2016 / 06 / 01）

1 - 11

繁體中文

系統性血管炎即血管受到自體免疫系統侵犯，發生炎性反應及壞死，導致所供應組織缺氧病變。從自體免疫系統攻擊全身血管組織至確診為血管炎時，往往已有不同程度的腎臟功能障礙。多重且善變的症狀與病程，不僅讓病人在承受病痛時倍感煎熬，還須面臨生命威脅的壓力，對於醫護人員更是重大的挑戰。本文以兩位血管炎續發腎臟損傷，接受腹膜透析個案的病程、症狀及困擾為例，進行相關文獻回顧，期能提供臨床照護此類病人之參考。

Systemic vasculitis is an inflammatory response characterized by vascular invasion and necrosis leading to tissue hypoxia. By the time of diagnosis, patients were often suffering from varying degrees of renal dysfunction and complications already. In addition to the multiple symptoms and unpredictable course of the disease, some patients also face lifethreatening conditions. In this article, two cases of end-stage renal disease secondary to systemic vasculitis are reported and the relevant literatures are reviewed.

1. 范曉雯,張瓈方,許育瑞,吳毓慧(2015)。一位抗嗜中性球細胞質抗體血管炎合併腎臟侵犯病人接受血液透析及血漿置換術之照護經驗。源遠護理，9(4)，63-70。
   連結：
2. Berger, D.(1999).A brief history of medical diagnosis and the birth of the clinical laboratory. Part 2--laboratory science and professional certification in the 20th century.Medical Laboratory Observer,31(8),32-34+36+38.
3. Berger, D.(1999).A brief history of medical diagnosis and the birth of the clinical laboratory. Part 1 - Ancient times through the 19th century.Medical Laboratory Observer,31(7),28-30.
4. Brown, S.(2012).Vasculitis: pathophysiology, diagnosis and treatment.Nursing Standard,27(12),50-57.
5. Frankel, S. K.,Sullivan, E. J.,Brown, K. K.(2002).Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis.Critical care clinics,18(4),855-879.
6. Grossman, J.,MacLean, C. H.(2007).Quality indicators for the care of osteoporosis in vulnerable elders.Journal of the American Geriatrics Society,55(s2),S392-S402.
7. Haubitz, M.,Koch, K. M.,Brunkhorst, R.(1998).Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.Nephrology Dialysis Transplantation,13(7),1713-1718.
8. Huang, C. K.,Fang, H. C.,Chou, K. J.,Wang, J. S.,Lee, P. T.,Chang, T. Y.,Chen, C. L.(2012).Clinical features of microscopic polyangiitis: a cohort study in a Southern Taiwan Medical Center.Acta Nephrologica,26(4),198-205.
9. Jennette, J.,Falk, R.,Bacon, P.,Basu, N.,Cid, M.,Ferrario, F.,Hagen, E.(2013).2012 revised international chapel hill consensus conference nomenclature of vasculitides.Arthritis & Rheumatism,65(1),1-11.
10. Johns Hopkins Vasculitis Center(2002).From Kussmaul to Kawasaki: Thumbnail sketches in the history of vasculitis, part I.Newsletter of Johns Hopkins Vasculitis Center,2(1),1-3+7.
11. Johns Hopkins Vasculitis Center(2003).From Kussmaul to Kawasaki: Thumbnail sketches in the history of vasculitis, part2 Wegener’s granulomatosis to Behçet’s disease.Newsletter of Johns Hopkins Vasculitis Center,2(2),6-9.
12. Lee, T.,Gasim, A.,Derebail, V. K.,Chung, Y.,McGregor, J. G.,Lionaki, S.,Falk, R. J.(2014).Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure.Clinical Journal of the American Society of Nephrology,9(5),905-913.
13. Lionaki, S.,Hogan, S. L.,Jennette, C. E.,Hu, Y.,Hamra, J. B.,Jennette, J. C.,Nachman, P. H.(2009).The clinical course of ANCA small-vessel vasculitis on chronic dialysis.Kidney international,76(6),644-651.
14. Matteson, E. L.(2002).Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitis.Current rheumatology reports,4(1),67-74.
15. Ntatsaki, E.,Carruthers, D.,Chakravarty, K.,D’Cruz, D.,Harper, L.,Jayne, D.,Venning, M.(2014).BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.Rheumatology,53(12),2306-2309.
16. Phillips, R. M.(2012).Vasculitis – Rare, debilitating, and deadly.Nursing made Incredibly Easy,10(6),28-36.
17. Romeu, M.,Couchoud, C.,Delarozière, J. C.,Burtey, S.,Chiche, L.,Harlé, J. R.,Jourde-Chiche, N.(2014).Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.Quarterly journal of medicine,107(7),545-555.
18. Tang, W.,Bose, B.,McDonald, S. P.,Hawley, C. M.,Badve, S. V.,Boudville, N.,Peh, C. A.(2013).The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.Clinical Journal of the American Society of Nephrology,8(5),773-780.
19. Van Wijngaarden, R. A. d. L.,Hauer, H. A.,Wolterbeek, R.,Jayne, D. R.,Gaskin, G.,Rasmussen, N.,Hagen, E. C.(2006).Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement.Journal of the American Society of Nephrology,17(8),2264-2274.
20. 呂政勳,沈玠妤,吳政翰,余家利(2013)。抗嗜中性球細胞質抗體相關血管炎患者之臨床表現與治療反應：單一醫學中心之回顧性研究。中華民國風濕病雜誌，27(2)，27-36。
21. 張璧月(2004)。新的心血管疾病危險因子：骨髓過氧化酶。中華民國醫檢會報，19(5)，93-98。

1. 楊宜青(2018)。免疫疾病患者面對透析的護理經驗。彰化護理，25(4)，5-6。